Transient suppression of pancreatic endocrine function in patients following brain death

Hiroyoshi Yoshida,Atsushi Hiraide,Toshiharu Yoshioka,Tsuyoshi Sugimoto

DOI: https://doi.org/10.1111/j.1399-0012.1996.tb00640.x

1996-02-01

Clinical Transplantation

Abstract:To investigate pancreatic endocrine function in brain‐dead patients, an intravenous glucose tolerance test (i.v. GTT) was performed in 8 brain‐dead subjects maintained using the combined administration of vasopressin (ADH) and catecholamines during the first 3 days following the onset of brain death. Ten healthy adults served as control subjects. Although plasma glucose concentrations markedly increased and exceeded 300 mg/dl in most subjects just after the onset of brain death, they decreased to less than 200 mg/dl in most subjects after 24 h. The early insulin release also was significantly lower in brain dead subjects compared to controls (p<0.01). The late insulin release was not decreased compared to controls but rather increased, which was accompanied by decreased glucose disappearance rate. The early insulin release recovered rapidly during the first 3 days following brain death without significant changes in the plasma hormone concentrations such as epinephrine, human growth hormone, thyroid‐stimulating hormone, triiodothyronine, thyroxine, cortisol, and glucagon. The early insulin release and the plasma glucose concentration just before i.v. GTT was negatively correlated (R= ‐0.55, p<0.05). We suggest awaiting recovery from hyperglycemia and early insulin release provides a reasonable approach to transplantation of the pancreas.

surgery,transplantation